PEP/PrEP through pharmacist prescribing (PEPPI)
Part of Infections clinical trials.
This study looks at how well pharmacists can provide PEP and PrEP (HIV prevention pills) using a special software called PEPPI. It aims to make it easier and faster for people to get these medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are a pharmacist or a patient seeking PEP or PrEP services
- Your pharmacy is part of the PEPPI program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new software program that helps pharmacists prescribe birth control. It aims to make getting hormonal contraception easier and faster for patients.
This study helps pharmacies that do not yet offer PrEP (the daily medicine that prevents HIV) learn how to start. It provides training and support on the basics of PrEP and how to make it financially sustainable.
This trial trains community pharmacists in Louisiana to prescribe PrEP, a daily medication that prevents HIV, and monitors how well the program works.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study is testing whether starting PrEP (daily pills to prevent HIV) right away in the emergency department helps people at high risk for HIV. It aims to make it easier to start protection before you leave the hospital.
This trial tests whether telehealth support can help people who inject drugs start and stay on PrEP (HIV prevention medicine). You will join several sessions and follow-up visits to see if this approach works better than standard care.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.